Answers are grounded in this paper and cite their sources.
Kaposi's sarcoma (KS) is a rare complication of hematopoietic stem cell transplantation (HSCT). Here, we report a case of disseminated KS in a pediatric patient after haploidentical HSCT that developed during secondary immunosuppression. Treatment with liposomal doxorubicin resulted in a complete metabolic response. This case highlights the importance of early diagnosis and stresses the need to consider KS in the differential diagnosis of cutaneous and systemic manifestations in patients following HSCT. The patient's parents gave consent to the use of their child's data, including photographs, for research purposes and in publications.
No takes yet. Share an insight, caveat, or question.
Lemeshev et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: